172 related articles for article (PubMed ID: 1082456)
21. Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge.
Holden HT; Kirchner H; Herberman RB
J Immunol; 1975 Aug; 115(2):327-31. PubMed ID: 168259
[TBL] [Abstract][Full Text] [Related]
22. Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants.
Igarashi T; Rodrigues D; Ting CC
J Immunol; 1979 Apr; 122(4):1519-27. PubMed ID: 156217
[TBL] [Abstract][Full Text] [Related]
23. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
24. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
[TBL] [Abstract][Full Text] [Related]
25. Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction.
Glaser M; Herberman RB; Kirchner H; Djeu JY
Cancer Res; 1974 Sep; 34(9):2165-71. PubMed ID: 4276482
[No Abstract] [Full Text] [Related]
26. Generation of memory cell-mediated immune responses after secondary infection of mice with pichinde virus.
Walker CM; Rawls WE; Rosenthal KL
J Immunol; 1984 Jan; 132(1):469-74. PubMed ID: 6317748
[TBL] [Abstract][Full Text] [Related]
27. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
28. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Einstein AB; Fass L; Fefer A
Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
[TBL] [Abstract][Full Text] [Related]
29. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.
Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P
Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269
[TBL] [Abstract][Full Text] [Related]
30. Characterization of effector lymphocytes associated with immunity to murine sarcoma virus (MSV) induced tumors. I. Physical properties of cytolytic T lymphocytes generated in vitro and of their immediate progenitors.
Plata R; MacDonald HR; Engers HD
J Immunol; 1976 Jul; 117(1):52-8. PubMed ID: 180182
[TBL] [Abstract][Full Text] [Related]
31. T helper cells in immune mice amplify the primary anti-tumor cytotoxic response.
Yu AS; Bernstein ID
J Immunol; 1982 Aug; 129(2):856-9. PubMed ID: 6177788
[TBL] [Abstract][Full Text] [Related]
32. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
Fuyama S; Yamamoto H; Fujii Y; Arai S
Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
[TBL] [Abstract][Full Text] [Related]
34. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT
J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090
[TBL] [Abstract][Full Text] [Related]
35. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.
Fink PJ; Rammensee HG; Bevan MJ
J Immunol; 1984 Oct; 133(4):1775-81. PubMed ID: 6332132
[TBL] [Abstract][Full Text] [Related]
36. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors.
Boyer PJ; Fahey JL
J Immunol; 1976 Jan; 116(1):202-9. PubMed ID: 128571
[TBL] [Abstract][Full Text] [Related]
38. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immune response in vitro. I. The development of suppressor cells and cytotoxic lymphocytes in mixed lymphocyte cultures.
Hirano T; Nordin AA
J Immunol; 1976 Apr; 116(4):1115-22. PubMed ID: 130426
[TBL] [Abstract][Full Text] [Related]
40. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
Sharma JM; Herberman RB; Djeu JY; Nunn ME
J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
